Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01607658Phase 2Completed
A Phase 2 trial of testosterone in female orgasmic disorder (FOD), sponsored by Acerus Pharmaceuticals. Started May 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01607658.